Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,199.00
-3.20 (-0.15%)
Jun 19, 2026, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 362.3 billion as of June 18, 2026. Its market cap has increased by 38.42% in one year.
Market Cap
362.30B
Enterprise Value
330.81B
Revenue
64.31B
Ranking
n/a
PE Ratio
35.31
Stock Price
2,199.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 362.30B, an increase of 21.94%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 362.30B | 27.70% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 762.76B |
| Alkem Laboratories | 642.48B |
| Glenmark Pharmaceuticals | 624.68B |
| Ipca Laboratories | 402.32B |
| Ajanta Pharma | 382.81B |
| Emcure Pharmaceuticals | 336.71B |
| Wockhardt | 326.79B |
| Piramal Pharma | 211.00B |